Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice

IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.

Données et ressources

Info additionnelle

Champ Valeur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward